1. Stocks
  2. Nectar Lifesciences Ltd.
  3. Swot
swot-logo

Nectar Lifesciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Nectar Lifesciences Ltd. has 16 Strengths, 10 Weaknesses, 1 Opportunities and 1 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Newly Affordable Stocks with Good Financials and Durability (subscription)

Value Stocks, Under Radar (DVM)

Stocks seeing month price declines, good financial durability, and newly affordable valuations (subscription)

Rising Net Cash Flow and Cash from Operating activity

Companies with high TTM EPS Growth

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

Companies with rising net profit margins - quarterly as well as TTM basis

Affordable Stocks - Stocks with Good Trendlyne Valuation Score

Growth in Net Profit with increasing Profit Margin (QoQ)

Growth in Quarterly Net Profit with increasing Profit Margin (YoY)

Increasing profits every quarter for the past 3 quarters

Increasing Revenue every quarter for the past 2 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Company able to generate Net Cash - Improving Net Cash Flow for last 2 years

Top Gainers

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Companies with High Promoter Pledge

Near 52 Week Low

Weak Momentum: Price below Short, Medium and Long Term Averages

RSI indicating price weakness

Highest fall from 52 Week High

High promoter stock pledges

Near 52 Week Low

Stocks Underperforming their Industry Price Change in the Quarter

FII / FPI or Institutions increasing their shareholding

Red Flags: Weakening Technicals and Share Price Decline

High Piotroski Score - Companies with strong financials

Stocks with improving cash flow, with good durability

Rising Delivery Percentage Compared to Prev Day